(Q49164152)

2 July 2018

title

p53 mutations occur in clinical, but not latent, human prostate carcinoma. (English)

1 reference

2 July 2018

author name string

N Konishi

1

1 reference

2 July 2018

Y Hiasa

2

1 reference

2 July 2018

I Hayashi

3

1 reference

2 July 2018

H Matsuda

4

1 reference

2 July 2018

T Tsuzuki

5

1 reference

2 July 2018

T Ming

6

1 reference

2 July 2018

Y Kitahori

7

1 reference

2 July 2018

T Shiraishi

8

1 reference

2 July 2018

R Yatani

9

1 reference

2 July 2018

J Shimazaki

10

1 reference

2 July 2018

publication date

1 January 1995

1 reference

2 July 2018

number of pages

7

1 reference

Japanese Journal of Cancer Research

inferred from page(s)

published in

1 reference

2 July 2018

volume

86

1 reference

2 July 2018

page(s)

57-63

1 reference

2 July 2018

issue

1

1 reference

2 July 2018

How many mutations are required for tumorigenesis? Implications from human cancer data

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920585

p53 is mutated in a subset of advanced-stage prostate cancers

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920585

Infrequent involvement of p53 gene mutations in the tumourigenesis of Japanese prostate cancer

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920585

Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920585

Mutations in the p53 gene occur in diverse human tumour types

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920585

Wild-type p53 can inhibit oncogene-mediated focus formation

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920585

The p53 proto-oncogene can act as a suppressor of transformation

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920585

Genetic mechanisms of tumor suppression by the human p53 gene

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920585

A genetic model for colorectal tumorigenesis

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920585

Association of human papillomavirus types 16 and 18 E6 proteins with p53.

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920585

Identification of p53 gene mutations in bladder cancers and urine samples

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920585

Allelic loss of chromosomes 16q and 10q in human prostate cancer

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920585

p53 mutations in human cancers

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920585

Deletion mapping of chromosomes 8, 10, and 16 in human prostatic carcinoma.

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920585

p53 mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920585

p53, c-erbB-2 and the epidermal growth factor receptor in the benign and malignant prostate

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920585

Mutations of p53 and ras genes in radon-associated lung cancer from uranium miners.

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920585

Alterations of the P53 gene are associated with the progression of a human prostate carcinoma

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920585

DNA sequencing with chain-terminating inhibitors

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920585

T antigen is bound to a host protein in SY40-transformed cells

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920585

Expression of nm23-H1 and nm23-H2 proteins in prostate carcinoma.

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5920585

Increased expression of mutant forms of p53 oncogene in primary lung cancer

14 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1349-7006.1995.TB02988.X

Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging

21 January 2018

1 reference

12 December 2020

Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells

1 reference

12 December 2020

p53 protein accumulation and gene mutation in the progression of human prostate carcinoma

1 reference

12 December 2020

Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies

1 reference

12 December 2020

Comparative analysis of p53 protein immunoreactivity in prostatic, lung and breast carcinomas.

1 reference

12 December 2020

Small Subgroup of Aggressive, Highly Proliferative Prostatic Carcinomas Defined by p53 Accumulation

1 reference

12 December 2020

Accumulated allelic losses in the development of invasive urothelial cancer

1 reference

12 December 2020

Mutation spectrum of the p53 gene in bone and soft tissue sarcomas

1 reference

12 December 2020

Studies of migrant populations

1 reference

12 December 2020

Detection of loss of heterozygosity in tumor DNA samples by PCR

1 reference

12 December 2020

Trends in frequency of latent prostate carcinoma in Japan from 1965-1979 to 1982-1986

1 reference

12 December 2020

K-ras activation and ras p21 expression in latent prostatic carcinoma in Japanese men

1 reference

12 December 2020

10.1111/J.1349-7006.1995.TB02988.X

Identifiers

DOI

1 reference

2 July 2018

PMCID

5920585

1 reference

2 July 2018

PubMed ID

7737911

1 reference

2 July 2018